Aurora kinase inhibitor

This page covers all Aurora kinase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Aurora B.

Targets

Aurora B

Phase 1 pipeline (1)

• AZD1152 part B · AstraZeneca · Oncology
  AZD1152 is a selective Aurora B kinase inhibitor that disrupts mitotic progression and leads to cell cycle arrest and apoptosis in cancer cells.

Patent intelligence

• aurora kinase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates